文献速递支持与姑息治疗

扩大癌症劳动力对2030至2050年全球癌症死亡率影响的模拟分析

Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types.
PubMed 文献 · Lancet Oncol · 2026-01-01

该研究利用全球癌症劳动力微观模拟模型,评估了200个国家中18类卫生人员扩增对17种癌症总死亡率的影响。

要点

  • 全面扩增所有劳动力水平可使55个国家癌症死亡率降低超过50%。
  • 非洲地区癌症劳动力短缺预计持续至2050年,需优先投资。

核心结论

  • 投资加强癌症劳动力对降低全球癌症死亡率至关重要。
  • 战略性地扩增人员,尤其是诊断领域,并结合数字健康与任务转移,可显著改善癌症结局。
  • 政策制定者应将数据驱动的劳动力规划作为综合癌症控制策略的关键组成部分。

研究设计与样本

  • 基于全球癌症劳动力微观模拟模型的模拟分析。
  • 覆盖200个国家和地区,17种癌症,18类卫生人员,时间范围为2030至2050年。
  • 劳动力密度基于多种来源估算,专家意见调查纳入16个国家86名专家的反馈。

主要发现

  • 预计2050年癌症劳动力仍存在显著差异,非洲短缺尤为严重。
  • 全面扩增所有劳动力水平预计使55个国家癌症死亡率降低超过50%,主要集中在非洲、中美洲和南亚。

临床怎么用

  • 政策制定应优先投资于癌症劳动力建设,特别是诊断与影像人员。
  • 可结合数字健康解决方案和任务转移等创新策略以增强效果。
  • 采用数据驱动的劳动力规划,针对不同国家异质性制定策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The global burden of cancer continues to rise, disproportionately affecting low-income and middle-income countries, where cancer workforce shortages are especially acute and contribute to poor outcomes. In this analysis, we estimate the effect on cancer mortality of scaling up specific workforce personnel types in order to provide global, regional, and country-specific guidance to inform cancer workforce policy. METHODS: Using the Global Cancer Workforce microsimulation model, which accounts for demographic, epidemiological, and health system factors related to cancer incidence and survival, we modelled the projected effect of scaling up 18 specific workforce personnel types on total cancer mortality (diagnosed and undiagnosed) from 17 cancers (oral, nasopharynx, oesophagus, stomach, colon, rectum, anus, liver, pancreas, lung, skin melanoma, breast, cervix uteri, ovary, prostate, bladder, and brain and CNS) in 200 countries and territories from 2030 to 2050. Workforce density (per 100 000 population) of each workforce personnel type was modelled based on estimates from various sources (including WHO Global Health Workforce Statistics, the IMAGINE database, and previous Lancet Commissions). Expert opinion surveys, with responses from 86 experts in 16 countries, informed the involvement of workforce personnel in specific model events. We also modelled scale-up of workforce by cadre (ie, teams of personnel that work together in a particular specialty) and level of training (ie, years of education). FINDINGS: Substantial disparities in cancer workforce were projected to persist in 2050, with especially large workforce shortages in Africa. Among single personnel types, scaling up surgeons was projected to yield the largest reduction in global cancer mortality (3·64% [95% uncertainty interval 2·68-4·66]), especially in Africa, Asia, and Oceania, but with considerable heterogeneity by country. Among workforce cadres, scaling up diagnostic and imaging personnel was projected to yield the greatest benefit (global cancer mortality reduction of 7·61% [5·23-9·88]), with some heterogeneity by country. Comprehensive scale-up of all workforce levels was projected to reduce cancer mortality by over 50% in 55 countries, most notably in Africa, central America, and southern Asia. INTERPRETATION: Investments to strengthen the cancer workforce will be essential to reduce global cancer mortality and improve timely diagnosis and survival. Strategic scale-up of personnel, particularly in diagnostics, alongside innovative strategies such as digital health solutions and role delegation, could result in substantial improvements in cancer outcomes. Policy makers should prioritise data-driven workforce planning as a crucial component of comprehensive cancer control strategies. FUNDING: American Cancer Society and Breast Cancer Research Foundation.

来源:Lancet Oncol,查看原文。版权归原作者所有。

引用

  1. Ward ZJ, Moraes FY, Scott AM, et al. Estimating the impact of scaling up workforce personnel on global cancer mortality from 2030 to 2050: a simulation-based analysis of 17 cancers and 18 personnel types. Lancet Oncol. 2026. PMID: 42061369. doi:10.1016/S1470-2045(26)00062-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。